Andrew Grieve is the CEO of Zenabis and he joined Business of Cannabis to talk about their agreement to grow Tantalus Labs genetics on contract as well as their stock offering to current shareholders – which has been the topic of conversation among those that follow publicly traded cannabis companies.
First CannEpil delivered to UK patients through I AM Billy Foundation and GMC Specialist Register
MGC Pharmaceuticals Ltd (“MGC Pharma”, “MGC” or the “Company”) a European based pharmaceutical company specialising in the production and development...
